Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Recruiting · NCT05806931 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Phase 2 | 2026-03-18 | NCT05806931 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rutgers, The State University of New Jersey | 154 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cooperman Barnabas Medical Center (Saint Barnabas Medical Center) | Livingston | United States | 3 |
| Rutgers Cancer Institute of New Jersey | New Brunswick | United States | 223 |
| RWJBarnabas Health - Community Medical Center | Toms River | United States | 9 |
| RWJBarnabas Health - Monmouth Medical Center | Long Branch | United States | 7 |
| RWJBarnabas Health - Monmouth Medical Center Southern Campus | Lakewood | United States | 8 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Somerset | United States | 3 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | New Brunswick | United States | 5 |
| RWJBarnabas Health Jersey City Medical Center | Jersey City | United States | 4 |
| Trinitas Hospital and Comprehensive Cancer Center | Elizabeth | United States | 5 |